These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

456 related articles for article (PubMed ID: 3346666)

  • 1. Formation of the neurotransmitter glycine from the anticonvulsant milacemide is mediated by brain monoamine oxidase B.
    Janssens de Varebeke P; Cavalier R; David-Remacle M; Youdim MB
    J Neurochem; 1988 Apr; 50(4):1011-6. PubMed ID: 3346666
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of the glycine prodrug milacemide (2-N-pentylaminoacetamide) on catecholamine secretion from isolated adrenal medulla chromaffin cells.
    Yadid G; Zinder O; Youdim MB
    Br J Pharmacol; 1991 Nov; 104(3):760-4. PubMed ID: 1797336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Is the oxidation of milacemide by monoamine oxidase a major factor in its anticonvulsant actions?
    O'Brien EM; Tipton KF; Strolin Benedetti M; Bonsignori A; Marrari P; Dostert P
    Biochem Pharmacol; 1991 Jun; 41(11):1731-7. PubMed ID: 2043162
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MAO activity, metabolism and anticonvulsant activity of milacemide in rats and mice.
    Colombo M; Strolin Benedetti M; Bonsignori A; Cocchiara G; Roncucci R; Dostert P
    J Neural Transm Suppl; 1990; 32():123-9. PubMed ID: 2089081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The interactions of milacemide with monoamine oxidase.
    O'Brien EM; Tipton KF; McCrodden JM; Youdim MB
    Biochem Pharmacol; 1994 Feb; 47(4):617-23. PubMed ID: 8129740
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Species differences in the interactions of the anticonvulsant milacemide and some analogues with monoamine oxidase-B.
    O'Brien EM; Dostert P; Tipton KF
    Biochem Pharmacol; 1995 Jul; 50(3):317-24. PubMed ID: 7646533
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The novel neuropsychotropic agent milacemide is a specific enzyme-activated inhibitor of brain monoamine oxidase B.
    Janssens de Varebeke P; Pauwels G; Buyse C; David-Remacle M; De Mey J; Roba J; Youdim MB
    J Neurochem; 1989 Oct; 53(4):1109-16. PubMed ID: 2769256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does FAD-dependent polyamine oxidase contribute to the metabolism of milacemide?
    Strolin Benedetti M; Cocchiara G; Colombo M; Dostert P
    J Neural Transm Suppl; 1990; 32():351-6. PubMed ID: 2128509
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interactions of some analogues of the anticonvulsant milacemide with monoamine oxidase.
    O'Brien EM; Dostert P; Pevarello P; Tipton KF
    Biochem Pharmacol; 1994 Aug; 48(5):905-14. PubMed ID: 8093103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drug pharmacokinetics and neuropharmacokinetics in individual rats by repetitive withdrawal of blood and cerebrospinal fluid: milacemide.
    Semba J; Curzon G; Patsalos PN
    Br J Pharmacol; 1993 Apr; 108(4):1117-24. PubMed ID: 8485621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible mechanism of selective inhibition of rat liver mitochondrial monoamine oxidase by chlorgiline and deprenyl].
    Severina IS
    Biokhimiia; 1979 Feb; 44(2):195-207. PubMed ID: 435561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet monoamine oxidase B: use and misuse.
    Youdim MB
    Experientia; 1988 Feb; 44(2):137-41. PubMed ID: 3278920
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoamine oxidase inhibitory properties of milacemide in rats.
    Truong DD; Diamond B; Pezzoli G; Mena MA; Fahn S
    Life Sci; 1989; 44(15):1059-66. PubMed ID: 2784529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of solubilization by methylethylketone of rat liver mitochondrial monoamine oxidase on inhibition by clorgyline and deprenyl of the enzyme activity].
    Severina IS; Klimova GI; Nersisian AA
    Biokhimiia; 1981 Nov; 46(11):2043-55. PubMed ID: 6797482
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Milacemide, a glycine pro-drug, inhibits strychnine-allodynia without affecting normal nociception in the rat.
    Khandwala H; Loomis CW
    Pain; 1998 Jul; 77(1):87-95. PubMed ID: 9755023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A new type of mitochondrial monoamine oxidase distinct from type-A and type-B.
    Kinemuchi H; Sudo M; Yoshino M; Kawaguchi T; Sunami Y; Kamijo K
    Life Sci; 1983 Jan; 32(5):517-24. PubMed ID: 6823208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-dependent differences in monoamine oxidase A and B-catalyzed oxidation of various C4 substituted 1-methyl-4-phenyl-1,2,3, 6-tetrahydropyridinyl derivatives.
    Inoue H; Castagnoli K; Van Der Schyf C; Mabic S; Igarashi K; Castagnoli N
    J Pharmacol Exp Ther; 1999 Nov; 291(2):856-64. PubMed ID: 10525109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123(1-6):13-26. PubMed ID: 22032088
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The properties of B-form monoamine oxidase in mitochondria from monkey platelet.
    Obata T; Aomine M
    Res Commun Mol Pathol Pharmacol; 2009-2010; 122-123():13-26. PubMed ID: 25022028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of vocal and nonvocal behavior in adult squirrel monkeys by selective MAO-A and MAO-B inhibition.
    Newman JD; Winslow JT; Murphy DL
    Brain Res; 1991 Jan; 538(1):24-8. PubMed ID: 1902133
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.